Tumor Suppressive Role of the PRELP Gene in Ovarian Clear Cell Carcinoma

被引:11
作者
Dozen, Ai [1 ,2 ]
Shozu, Kanto [1 ,3 ]
Shinkai, Norio [1 ,4 ,5 ]
Ikawa, Noriko [1 ]
Aoyama, Rina [1 ,6 ]
Machino, Hidenori [1 ,4 ]
Asada, Ken [1 ,4 ]
Yoshida, Hiroshi [7 ]
Kato, Tomoyasu [8 ]
Hamamoto, Ryuji [1 ,4 ,5 ]
Kaneko, Syuzo [1 ]
Komatsu, Masaaki [4 ]
机构
[1] Natl Canc Ctr, Div Med AI Res & Dev, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[2] Keio Univ, Dept Obstet & Gynecol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan
[3] Univ Toyama, Dept Obstet & Gynecol, 2630 Sugitani, Toyama 9300194, Japan
[4] RIKEN Ctr Adv Intelligence Project, Canc Translat Res Team, Chuo Ku, 1-4-1 Nihonbashi, Tokyo 1030027, Japan
[5] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept NCC Canc Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan
[6] Showa Univ, Dept Obstet & Gynecol, Sch Med, Shinagawa Ku, Tokyo 1428666, Japan
[7] Natl Canc Ctr, Dept Diagnost Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[8] Natl Canc Ctr, Dept Gynecol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
关键词
ovarian clear cell carcinoma; PRELP; gene expression; epigenetics; PROGNOSTIC VALUE; ENDOMETRIOSIS; EXPRESSION; INHIBITORS; CANCER; PROTEOGLYCAN; EPIDEMIOLOGY; MUTATIONS; GENOME; PIK3CA;
D O I
10.3390/jpm12121999
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Ovarian clear cell carcinoma (OCCC) has a poor prognosis, and its therapeutic strategy has not been established. PRELP is a leucine-rich repeat protein in the extracellular matrix of connective tissues. Although PRELP anchors the basement membrane to the connective tissue and is absent in most epithelial cancers, much remains unknown regarding its function as a regulator of ligand-mediated signaling pathways. Here, we obtained sets of differentially expressed genes by PRELP expression using OCCC cell lines. We found that more than 1000 genes were significantly altered by PRELP expression, particularly affecting the expression of a group of genes involved in the PI3K-AKT signaling pathway. Furthermore, we revealed the loss of active histone marks on the loci of the PRELP gene in patients with OCCC and how its forced expression inhibited cell proliferation. These findings suggest that PRELP is not only a molecule anchored in connective tissues but is also a signaling molecule acting in a tumor-suppressive manner. It can serve as the basis for early detection and novel therapeutic approaches for OCCC toward precision medicine.
引用
收藏
页数:14
相关论文
共 43 条
[1]   Integrated Analysis of Whole Genome and Epigenome Data Using Machine Learning Technology: Toward the Establishment of Precision Oncology [J].
Asada, Ken ;
Kaneko, Syuzo ;
Takasawa, Ken ;
Machino, Hidenori ;
Takahashi, Satoshi ;
Shinkai, Norio ;
Shimoyama, Ryo ;
Komatsu, Masaaki ;
Hamamoto, Ryuji .
FRONTIERS IN ONCOLOGY, 2021, 11
[2]   Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions [J].
Bai, Huimin ;
Cao, Dongyan ;
Yuan, Fang ;
Sha, Guihua ;
Yang, Jiaxin ;
Chen, Jie ;
Wang, Yue ;
Zhang, Zhenyu ;
Shen, Keng .
GYNECOLOGIC ONCOLOGY, 2016, 143 (03) :526-531
[3]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[4]   The Soft Agar Colony Formation Assay [J].
Borowicz, Stanley ;
Van Scoyk, Michelle ;
Avasarala, Sreedevi ;
Rathinam, Manoj Kumar Karuppusamy ;
Tauler, Jordi ;
Bikkavilli, Rama Kamesh ;
Winn, Robert A. .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (92)
[5]   Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer [J].
Bowtell, David D. ;
Boehm, Steffen ;
Ahmed, Ahmed A. ;
Aspuria, Paul-Joseph ;
Bast, Robert C., Jr. ;
Beral, Valerie ;
Berek, Jonathan S. ;
Birrer, Michael J. ;
Blagden, Sarah ;
Bookman, Michael A. ;
Brenton, James D. ;
Chiappinelli, Katherine B. ;
Martins, Filipe Correia ;
Coukos, George ;
Drapkin, Ronny ;
Edmondson, Richard ;
Fotopoulou, Christina ;
Gabra, Hani ;
Galon, Jerome ;
Gourley, Charlie ;
Heong, Valerie ;
Huntsman, David G. ;
Iwanicki, Marcin ;
Karlan, Beth Y. ;
Kaye, Allyson ;
Lengyel, Ernst ;
Levine, Douglas A. ;
Lu, Karen H. ;
McNeish, Iain A. ;
Menon, Usha ;
Narod, Steven A. ;
Nelson, Brad H. ;
Nephew, Kenneth P. ;
Pharoah, Paul ;
Powell, Daniel J., Jr. ;
Ramos, Pilar ;
Romero, Iris L. ;
Scott, Clare L. ;
Sood, Anil K. ;
Stronach, Euan A. ;
Balkwill, Frances R. .
NATURE REVIEWS CANCER, 2015, 15 (11) :668-679
[6]   The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data [J].
Cerami, Ethan ;
Gao, Jianjiong ;
Dogrusoz, Ugur ;
Gross, Benjamin E. ;
Sumer, Selcuk Onur ;
Aksoy, Buelent Arman ;
Jacobsen, Anders ;
Byrne, Caitlin J. ;
Heuer, Michael L. ;
Larsson, Erik ;
Antipin, Yevgeniy ;
Reva, Boris ;
Goldberg, Arthur P. ;
Sander, Chris ;
Schultz, Nikolaus .
CANCER DISCOVERY, 2012, 2 (05) :401-404
[7]   Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinoma [J].
Chao, Angel ;
Lai, Chyong-Huey ;
Wang, Tzu-Hao ;
Jung, Shih-Ming ;
Lee, Yun-Shien ;
Chang, Wei-Yang ;
Yang, Lan-Yang ;
Ku, Fei-Chun ;
Huang, Huei-Jean ;
Chao, An-Shine ;
Wang, Chin-Jung ;
Chang, Ting-Chang ;
Wu, Ren-Chin .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (06) :527-536
[8]   Small leucine rich proteoglycan family regulates multiple signalling pathways in neural development and maintenance [J].
Dellett, Margaret ;
Hu, Wanzhou ;
Papadaki, Vasiliki ;
Ohnuma, Shin-ichi .
DEVELOPMENT GROWTH & DIFFERENTIATION, 2012, 54 (03) :327-340
[9]   A phase II evaluation of temsirolimus in combination with carboplatin and paclitaxel followed by temsirolimus consolidation as first-line therapy in the treatment of stage III-IV clear cell carcinoma of the ovary. [J].
Farley, John H. ;
Brady, William E. ;
Fujiwara, Keiichi ;
Nomura, Hiroyuki ;
Yunokawa, Mayu ;
Tokunaga, Hideki ;
Saitou, Motoaki ;
Gershenson, David Marc .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[10]   Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer [J].
Fukumoto, Takeshi ;
Park, Pyoung Hwa ;
Wu, Shuai ;
Fatkhutdinov, Nail ;
Karakashev, Sergey ;
Nacarelli, Timothy ;
Kossenkov, Andrew V. ;
Speicher, David W. ;
Jean, Stephanie ;
Zhang, Lin ;
Wang, Tian-Li ;
Shih, Ie-Ming ;
Conejo-Garcia, Jose R. ;
Bitler, Benjamin G. ;
Zhang, Rugang .
CELL REPORTS, 2018, 22 (13) :3393-3400